You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 10, October 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Radiation Therapy
 •Endocrine Surgery
 •Diagnosis
 •Endocrine Diseases
 •Thyroid/ Parathyroid Diseases
 •Alert me on articles by topic

Diagnosis and Therapeutic Strategy for Papillary Thyroid Microcarcinoma

Jen-Der Lin, MD; Szu-Tah Chen, MD; Tzu-Chieh Chao, MD, PhD; Chuen Hsueh, MD; Hsiao-Fen Weng, MS

Arch Surg. 2005;140:940-945.

Hypothesis  Total thyroidectomy followed by radioactive iodine I 131 treatment is effective in papillary thyroid microcarcinoma (PTM) with lymph node or extrathyroid invasion.

Design  Retrospective study.

Setting  Chang Gung Medical Center, Linkou, Taiwan.

Patients  A total of 227 patients with PTM, categorized into high-risk (n = 12) and low-risk (n = 215) groups according to age, metastases, extent, and size criteria.

Interventions  Diagnosis and treatment of PTM.

Main Outcome Measures  Time and method of diagnosis, operative method, metastases, and survival.

Results  In 51 patients, PTM was identified on preoperative fine-needle aspiration cytology; in 75 patients, diagnosed in frozen sections during operation; and in 101 patients, diagnosed incidentally in the final histopathological examination. Among these 3 groups, 18% (9/51), 17% (13/75), and 78% (79/101), respectively, underwent subtotal thyroidectomy or lobectomy for tumors. Four cases (1.8%) displayed distant metastases at diagnosis. Only 0.9% of patients with PTM (2 of 227) died of thyroid cancer. One hundred eighty-nine cases of PTM were confined to the thyroid, 22 had lymph node metastases, and 16 showed extrathyroid extension, including soft-tissue invasion and distant metastases. Sex, operative methods, follow-up status, and mortality showed differences in these groups. Five of 227 patients remained in non–disease-free status at follow-up.

Conclusions  Approximately 10% of PTMs exhibited progressive clinical courses, while less than 1% resulted in mortality. Age, sex, and postoperative thyroglobulin level were the main prognostic factors in the high-risk group of patients with PTM. Conservative treatment of the incidental finding of PTM after suitable postoperative assessment is justified.


Author Affiliations: Division of Endocrinology and Metabolism, Department of Internal Medicine (Drs Lin, Chen, and Ms Weng), Department of General Surgery (Dr Chao), and Department of Pathology (Dr Hsueh), Chang Gung Memorial Hospital, Chang Gung University, Linkou, Taiwan.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thyroid papillary microcarcinoma: a descriptive and meta-analysis study
Roti et al.
Eur J Endocrinol 2008;159:659-673.
ABSTRACT | FULL TEXT  

Central Cervical Nodal Metastasis from Papillary Thyroid Microcarcinoma: Pattern and Factors Predictive of Nodal Metastasis
Roh et al.
Ann. Surg. Oncol. 2008;15:2482-2486.
ABSTRACT | FULL TEXT  

BRAF(V600E) mutation and the biology of papillary thyroid cancer
Frasca et al.
Endocr Relat Cancer 2008;15:191-205.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.